$SPL 0.145 on pump news $52m MCRange (creation) trade on news of some description.
ST target in blue.
Ill be very surprised if this doesnt at least close HOD
350m SOI
US listing SPHRY
Holding from 145
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.020 AUD
−8.16 M AUD
8.29 M AUD
392.73 M
About STARPHARMA HOLDINGS LIMITED
Sector
CEO
Cheryl Maley
Headquarters
Abbotsford
Website
Founded
1997
ISIN
AU000000SPL0
FIGI
BBG000BW3K53
Starpharma Holdings Ltd. engages in the research, development, and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its pipeline and products include SN38, cabazitaxel, docetaxel, radiopharmaceuticals, antibody-drug conjugates, and anti-infective products. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
$SPL ASX - Starpharma Holdings might be a small playStarpharma Holdings Limited (SPL) is a biotechnology company that engages in the development of dendrimer products for pharmaceutical, life science and other applications. SPL's underlying technology is built around dendrimers, a type of synthetic nanoscale polymer that is highly regular in size and
Speculative Stockpick #2SPL is a highly speculative stock (refer VectorVest Strategic Investment Matrix) with RV <1.0 and RS = 1.0.
We only consider this stock for very short term because of its explosive potential… A strong RT value.
The RT value is trending up since the confirmation of bullish abandoned baby which is
SPL.AX Starphrama poised for future gainsStarpharma is posting some nice technicals that may be indicative of another impulse move
See previous analysis on Starpharma
Vectorvest VS Technical AnalysisVectorvest VS technical analysis
Strategy | Entry Price
Midas Touch MA RT(40) crossover | $0.69
Midas Touch MA Stop (10 & 60 ) crossover | $0.74
DEW Crossover | $0.69
MACD Crossover
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SPL is 0.110 AUD — it has decreased by −4.35% in the past 24 hours. Watch STARPHARMA HOLDINGS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange STARPHARMA HOLDINGS LIMITED stocks are traded under the ticker SPL.
SPL stock has risen by 4.76% compared to the previous week, the month change is a 22.22% rise, over the last year STARPHARMA HOLDINGS LIMITED has showed a −21.43% decrease.
SPL stock is 4.55% volatile and has beta coefficient of −0.01. Track STARPHARMA HOLDINGS LIMITED stock price on the chart and check out the list of the most volatile stocks — is STARPHARMA HOLDINGS LIMITED there?
Yes, you can track STARPHARMA HOLDINGS LIMITED financials in yearly and quarterly reports right on TradingView.
STARPHARMA HOLDINGS LIMITED is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
SPL net income for the last half-year is −7.13 M AUD, while the previous report showed −1.03 M AUD of net income which accounts for −589.65% change. Track more STARPHARMA HOLDINGS LIMITED financial stats to get the full picture.
No, SPL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 40.00 employees. See our rating of the largest employees — is STARPHARMA HOLDINGS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STARPHARMA HOLDINGS LIMITED EBITDA is −14.04 M AUD, and current EBITDA margin is −169.43%. See more stats in STARPHARMA HOLDINGS LIMITED financial statements.
Like other stocks, SPL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STARPHARMA HOLDINGS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STARPHARMA HOLDINGS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STARPHARMA HOLDINGS LIMITED stock shows the sell signal. See more of STARPHARMA HOLDINGS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.